THE WHAT? Beiersdorf’s La Prairie has named Philippe Lamy as its new CEO, taking over from Patrick Rasquinet, effective April 2, 2022. Rasquinet will now focus on the broader role within the Beiersdorf Executive Board, where he is responsible for the whole Pharmacy & Selective Division.
THE DETAILS Lamy joins the prestige skin care brand from Loro Piana where he has held the role of Managing Director for the EMEA region since 2016. He also counts senior roles at Hermes’ Chinese brand, Shang Xia and L’Oréal among his prior experience.
“It is a great honor for me to take up this role at La Prairie and I am very excited by the opportunities ahead. The La Prairie House is magnificent, and the company has relentlessly built up its brand positioning in the last few years.”
THE WHY? Patrick Rasquinet, Beiersdorf Executive Board member commented, “In Philippe we have found a strong leader, a forward-thinking strategist, and a luxury retail industry insider. He has all the credentials to drive La Prairie forward over the coming years and help the company fulfil its potential of becoming the kind of legendary luxury house that we envision. I am delighted to welcome him to the Beiersdorf Group and to leave La Prairie in his very capable hands. I look forward to working closely with him to make our vision come true.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
